Independent Director and Seasoned Healthcare Executive Walt Rosebrough Elected Executive Chair; Search for CEO Underway

The Cooper Companies faces a critical transition as post-pandemic demand normalization in its vision care segment leads to decelerating revenue growth, falling to just 0.6% in the latest quarter.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue growth has decelerated significantly to 0.6% in 2026Q3 from a high of 9.8% in 2024Q4, while gross margins have exhibited high volatility, swinging from 56.4% in 2025Q4 to 68.0% in 2026Q2.
The company has provided optimistic earnings guidance for fiscal year 2026, expecting total revenue of $4.285 billion - $4.321 billion with organic growth of 3.5% to 4.5%.
The Cooper Companies reported strong fourth-quarter and full-year 2025 results, with sales rising to $1,065.2 million and $4,092.4 million respectively, alongside positive net income and diluted EPS.
The company operates 130 primary and specialty care offices with 1,900 physicians and advanced practice providers, offering expert care in 95 specialties, indicating a strong and diversified healthcare presence.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Sep 9, 2026 | $1.15+2.7% vs $1.12 | $1.1B-2.9% vs $1.1B |
Q3 2026 Jun 4, 2026 | $1.21+10.0% vs $1.10 | $1.1B+2.6% vs $1.1B |
Q2 2026 Mar 5, 2026 | $1.10+6.8% vs $1.03 | $1.0B+0.0% vs $1.0B |
Q4 2025 Dec 4, 2025 | $1.15+3.6% vs $1.11 | $1.1B+0.4% vs $1.1B |
Independent Director and Seasoned Healthcare Executive Walt Rosebrough Elected Executive Chair; Search for CEO Underway

The Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock?

The disposition involved 12,000 shares at a weighted average price of $58.89 per share, totaling ~$707,000. The transaction size was equal to 3% of the equity stake held before the filing.
Activist investor Jana Partners on Friday urged Cooper Companies to launch an external search for a new CEO and consider asset sales, arguing recent missteps have hurt investor confidence and weighed on the medical device maker's market value.
Benchmark COO against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for The Cooper Companies, Inc. (COO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $62.36 | $12.16B | 21.15 | 5.06% | 13.46% | 6.88% | — | |
| $19.99 | $7.14B | -65.09 | 6.47% | -2.05% | -1.71% | — | |
| $102.14 | $58.81B | 57.77 | 11.55% | 15.3% | 9.65% | — | |
| $86.05 | $9.8B | 23.00 | 4.03% | 3.07% | 8.83% | — | |
| $276.22 | $664.92B | 42.02 | 6.05% | 16.2% | 19.55% | 1.85% | |
| $109.93 | $191.48B | 40.64 | 5.67% | 9.75% | 9% | 2.14% |
The Cooper Companies, Inc. (COO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
The Cooper Companies, Inc. (COO) SEC filings — annual & quarterly reports (10-K, 10-Q)
Sep 9, 2026·SEC
Jun 4, 2026·SEC
May 4, 2026·SEC
Get notified when COO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
The Cooper Companies, Inc. (COO) stock FAQ — growth, dividends, profitability & financials explained
The Cooper Companies, Inc. (COO) reported $4.24B in revenue over the trailing twelve months. Revenue was $4.09B in fiscal year 2025. That is 3651% more than the $109.1M of fiscal year 1996.
The Cooper Companies, Inc. (COO) grew revenue by 4.7% over the trailing twelve months, compared with the twelve months before.
Yes. The Cooper Companies, Inc. (COO) earned $570.3M in net income over the trailing twelve months (a 13.5% net margin).
The Cooper Companies, Inc. (COO) had a return on equity (ROE) of 6.9% over the trailing twelve months. That is below the market's typical 10-15%.
The Cooper Companies, Inc. (COO) generated $678.0M in free cash flow over the trailing twelve months.